CN106479987B - 一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 - Google Patents
一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 Download PDFInfo
- Publication number
- CN106479987B CN106479987B CN201610806990.7A CN201610806990A CN106479987B CN 106479987 B CN106479987 B CN 106479987B CN 201610806990 A CN201610806990 A CN 201610806990A CN 106479987 B CN106479987 B CN 106479987B
- Authority
- CN
- China
- Prior art keywords
- mdpropo1
- housefly
- buffer solution
- recombinant protein
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000257159 Musca domestica Species 0.000 title claims abstract description 34
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title claims abstract description 28
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000004153 renaturation Methods 0.000 claims abstract description 31
- 210000003000 inclusion body Anatomy 0.000 claims abstract description 28
- 230000014509 gene expression Effects 0.000 claims abstract description 21
- 239000013604 expression vector Substances 0.000 claims abstract description 12
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 9
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 9
- 238000004925 denaturation Methods 0.000 claims abstract description 9
- 230000036425 denaturation Effects 0.000 claims abstract description 9
- 239000007800 oxidant agent Substances 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 239000003139 biocide Substances 0.000 claims abstract description 5
- 238000010276 construction Methods 0.000 claims abstract description 4
- 238000003259 recombinant expression Methods 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 56
- 102000004169 proteins and genes Human genes 0.000 claims description 50
- 235000018102 proteins Nutrition 0.000 claims description 47
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 150000001413 amino acids Chemical group 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 108010042407 Endonucleases Proteins 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 230000009465 prokaryotic expression Effects 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims 12
- 102000004533 Endonucleases Human genes 0.000 claims 2
- 241000588722 Escherichia Species 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 13
- 241000588724 Escherichia coli Species 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 8
- 230000006698 induction Effects 0.000 abstract description 7
- 230000001590 oxidative effect Effects 0.000 abstract description 7
- 229940124452 immunizing agent Drugs 0.000 abstract description 5
- 238000000855 fermentation Methods 0.000 abstract description 3
- 230000004151 fermentation Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 2
- 241001052560 Thallis Species 0.000 abstract 1
- 108010069727 pro-phenoloxidase Proteins 0.000 description 16
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 241000257226 Muscidae Species 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 9
- 108700026244 Open Reading Frames Proteins 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 210000000087 hemolymph Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- 229910001431 copper ion Inorganic materials 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 108060003552 hemocyanin Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 101001091421 Spodoptera litura Phenoloxidase 1 Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000007970 thio esters Chemical group 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 241001555556 Ephestia elutella Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000257229 Musca <genus> Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000031729 antibacterial peptide production Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 108010072676 prephenoloxidase-activating enzyme Proteins 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及家蝇MdproPO1重组蛋白的制备方法及其应用。其制备方法包括以下步骤:1)构建mdproPO1/pET‑30a重组表达载体;2)筛选高表达MdproPO1重组蛋白的表达菌株mdproPO1/pET‑30a/Rosetta;3)表达菌株的发酵培养与诱导表达;4)MdproPO1包涵体的变性与复性。该法用大肠杆菌表达系统生产出的家蝇酚氧化酶原(MdproPO1)表达量高,通过原核菌体回收、破碎,可以获得大量的MdproPO1包涵体,通过MdproPO1包涵体的变性与复性,可以获得可溶的有酶活性的MdproPO1重组蛋白。MdproPO1重组蛋白可以发展为灭蝇剂、氧化剂、黑化剂以及免疫剂,应用到卫生、保健、生物与化工等多个领域。
Description
技术领域
本发明涉及一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用,属于基因工程技术领域。
背景技术
家蝇是广布全球的卫生害虫,可以传播细菌、病毒和寄生虫等上百种病原体,但其自身却能够良好的生存,这完全得益于家蝇有一个强大的先天免疫系统。
昆虫缺乏获得性免疫,对入侵病原的防御完全依靠先天免疫。昆虫的先天免疫包括细胞免疫和体液免疫两部分。细胞免疫主要指血细胞对病原的包被、吞噬等作用;体液免疫指抗菌因子如抗菌肽的产生和黑化作用等。其中的黑化作用是由酚氧化酶原激活系统(prophenoloxidase-activated system,proPO系统)完成。proPO系统是昆虫免疫体系的重要成员,对病原入侵能做出最快速的免疫应答,不仅影响黑色素合成,还影响昆虫的发育与寿命,并与抗菌肽产生有关,在识别与防御病原中起关键作用。
通过几个昆虫proPO系统的研究,发现proPO系统的激活是一个丝氨酸蛋白酶级联反应:上游的丝氨酸蛋白酶水解下游酶的酶原,活化的酶再去激活下一个酶的酶原,最终将酚氧化酶原(prophenoloxidase,proPO)激活为酚氧化酶(phenoloxidases,PO)。PO是proPO系统中最后的也是最重要的功能组分,能将酚氧化成苯醌,进而形成不溶性的黑色素。一般,PO以无活性的proPO存在于血细胞里。proPO基因在昆虫中广泛存在,如埃及按蚊有10个,果蝇有3个,家蚕与烟草天娥各有2个,而蜜蜂只有1个。昆虫proPO基因的多样与其参与机体黑化、伤口愈合、血细胞聚集和表皮鞣化等多种功能有关。但是,目前对家蝇有几个proPO基因以及这些proPO基因重组的蛋白具有什么样的功能还不清楚。
通过转录组分析,发现家蝇有2个proPO基因,称其为mdproPO1与mdproPO2,具体见论文[Dianxiang Li,Yongli Liang, Xianwei Wang, Lei Wang, Mei Qi, Yang Yu,Yuanyuan Luan. Transcriptomic analysis of Musca domestica to reveal key genesof the prophenoloxidase-activating system. G3 (Bethesda). 2015;5(9):1827-1841.(SCI)]。mdproPO1基因含有一个开放阅读框(ORF),编码的MdproPO1蛋白无信号肽,有典型的保守区:一个酪氨酸酶保守区,一个硫酯基序保守区,一个酚氧化酶原激活酶(proPO-activating enzyme,PAP)裂解位点,两个结合铜离子的保守区(每个保守区都有三个组氨酸残基,可与铜离子以共价键结合,两个铜离子与氧原子结合)。但是,并不清楚MdproPO1蛋白是否具备被蛋白酶水解为活性MdPO1的功能,更不知道其具体的功效。
发明内容
为了解决以上技术问题,本发明提供了一种利用原核表达系统生产的可溶性家蝇MdproPO1重组蛋白,同时,提供了其应用。
本发明的技术方案为:扩增mdproPO1基因的开放阅读框(ORF)cDNA片段,构建mdproPO1/pET-30a重组表达载体,表达MdproPO1重组蛋白,进行开发应用。
表达载体的构建:依据家蝇mdproPO1基因ORF的两端序列和载体pET-30a的多克隆位点,设计一对上下游引物mdproPO1 ExF与mdproPO1 ExR,并在引物的5’端引入Kpn I与Sal I酶切位点,用大肠杆菌(Escherichia coli)和金黄色葡萄球菌(Staphylococcus aureus)混合液诱导的家蝇幼虫的cDNA为模板,PCR钓取mdproPO1片段,利用Kpn I与Sal I两个酶切位点,与pET-30a载体定向连接,构建mdproPO1/pET-30a表达载体,经测序证明该表达载体中的mdproPO1序列正确。
家蝇MdproPO1完整的核苷酸和推断的氨基酸序列:
atg cac cat cat cat cat cat tct tct ggt ctg gtg cca cgc ggt tct ggtatg
M H H H H H H S S G L V P R G S G M
aaa gaa acc gct gct gct aaa ttc gaa cgc cag cac atg gac agc cca gatctg ggt acc
K E T A A A K F E R Q H M D S P D LG T
atgactgacaaaaagaatctcctgttgctgttcgaccgccccaccgaaccggtgttcatg
M T D K K N L L L L F D R P T E P V F M
ggaaagggcaaaacatcgacggtcttcgatgttcccgacaagtacttgacaaaacgttac
G K G K T S T V F D V P D K Y L T K R Y
gaacgtttgggcaatgaaatccaaagtcgtttcggcgaaaaggctgaacaacgtgtaccg
E R L G N E I Q S R F G E K A E Q R V P
gttaggggaatatccctgcccgatttacgtattcccatgtccttgggtcgtgatgaacaa
V R G I S L P D L R I P M S L G R D E Q
ttctcattgttcgtgccacgtcatcgtcgcattgcgggtcgcttgattgacattttcgtt
F S L F V P R H R R I A G R L I D I F V
ggcatgcgcaccgttgatgatttgctcagtgttgctgtgtatgcccgtgatcgtgtcaat
G M R T V D D L L S V A V Y A R D R V N
ccctatttgttcaattatgccctctcggtggctttgttgcatcgcgaagataccaagggt
P Y L F N Y A L S V A L L H R E D T K G
ttggatttgccctcgtttgcccagaatttccccgataagtttgtggattcccaggtcttc
L D L P S F A Q N F P D K F V D S Q V F
cgtcaggtgagagaggaagccacagtcgtgcccgatggatctcgcatgccaattgtagtt
R Q V R E E A T V V P D G S R M P I V V
cctcgtgactataccgcttccgatttggatcccgaacatcgtctgtggtatttccgtgag
P R D Y T A S D L D P E H R L W Y F R E
gatatgggcatcaatcttcatcactggcattggcatttggtttatcctttcgaggctggg
D M G I N L H H W H W H L V Y P F E A G
gatcgccgtattgtcgagaaggatcgtcgcggtgaacttttctattacatgcatcaacag
D R R I V E K D R R G E L F Y Y M H Q Q
gtcattgcccgctacaacatggaacgtttcagcagcaatttggcccgtgtcactagattc
V I A R Y N M E R F S S N L A R V T R F
aacaacttccgtgaacccattgctgaaggttatttccccaagatggattcactggttgcc
N N F R E P I A E G Y F P K M D S L V A
agccgtgcttggccaccacgtttcgataatactcccatcaaagatttgaatcgtgaattg
S R A W P P R F D N T P I K D L N R E L
gatcaaatcaatttggacatttcagacttggaaagatggcgtgatcgtattttcgaggcc
D Q I N L D I S D L E R W R D R I F E A
atccatcaaggatttgtggtcgatgccagcggcaatcgtattcccttggatgaacgtcgt
I H Q G F V V D A S G N R I P L D E R R
ggtattgatattctgggtaatatgttggaagcttccatcatttcacccaatcaatcggtg
G I D I L G N M L E A S I I S P N Q S V
tatggtgatttccataacatgggtcatgtcttcatttcctatgcccacgatcctgatcat
Y G D F H N M G H V F I S Y A H D P D H
cgccatctggagtcattcggcgtaatgggtgattcagccactgccatgcgtgatcctgtc
R H L E S F G V M G D S A T A M R D P V
ttctacagatggcatgcctatattgatgatattttccaagaacacaagacccgtctgaca
F Y R W H A Y I D D I F Q E H K T R L T
ccctacaccttgcctcaattgcaatatgatggtatatccatatctggactccaggttagc
P Y T L P Q L Q Y D G I S I S G L Q V S
tctgagggtggtcaacccaatgttttgagcacattctggcaacaatcggatgttgatttg
S E G G Q P N V L S T F W Q Q S D V D L
tcccgtggcatgggcttcgtgccacgcggtaatgtctttgcccgtttcactcatttgcaa
S R G M G F V P R G N V F A R F T H L Q
cacacacccttcacctataccattaatgtcaacaatgacagtggcgcccaacgttttggc
H T P F T Y T I N V N N D S G A Q R F G
accgtacgcatcttcatagcccccaagaccgatgaacgtggtcagccatggttgttccgc
T V R I F I A P K T D E R G Q P W L F R
gatcaacgtctgatgatggtggagttggataagtttgttgtgcaattgaatcctggccaa
D Q R L M M V E L D K F V V Q L N P G Q
aacacaattcgccgccgttcaacagattccagtgttaccattccatttgaacgtaccttc
N T I R R R S T D S S V T I P F E R T F
cgcaacttggaggttaatcgcccagcccaaggtagccccgaagaattggaattcaatttc
R N L E V N R P A Q G S P E E L E F N F
tgcggctgtggctggcctcagcatatgttgataccaaagggtttgcccggtggcatgcgt
C G C G W P Q H M L I P K G L P G G M R
tgtgaactgtttgtcatggtctccaattatgaagatgatcgggttgatcaaaccctggtc
C E L F V M V S N Y E D D R V D Q T L V
ggtgcctgcagtgatgccgcctcatactgtggtgtccgtgatcgtctctatcccgatcgt
G A C S D A A S Y C G V R D R L Y P D R
cgcgccatgggttatcccttcgatcgtttgcctcgtcaaggtgttgatcgtttggtccaa
R A M G Y P F D R L P R Q G V D R L V Q
ttcctaacacccaacatgagcattgttgatgtatcgattcgtcatgatgccaacagagtt
F L T P N M S I V D V S I R H D A N R V
gtaatgagacaataa
V M R Q *
以上为mdproPO1/pET-30a表达载体表达的MdproPO1重组蛋白的核苷酸序列(SEQID N0.1)与推断的氨基酸序列(SEQ ID N0.2)。其中,核苷酸序列总长2169 bp,包括2055bp的MdproPO1的ORF、N端114 bp来自载体的带组氨酸His的标签(,终止密码子用星号*表示,Kpn I酶切位点。推断的MdproPO1氨基酸序列中的保守序列有Hemocyanin_N 22-140、Hemocyanin_M 146-412、Hemocyanin_C 421-675三个血蓝蛋白保守区;一个酪氨酸酶(tyrosinase)保守区 201-418;一个保守的硫酯基序582-589;一个酚氧化酶原激活酶(proPO-activating enzyme,PAP)裂解位点*R51-*F52;两个铜离子结合位点:196-245和357-412。
转化子筛选、发酵培养与MdproPO1诱导表达:将构建好的mdproPO1/pET-30a表达载体转化大肠杆菌Rosetta感受态细胞,经卡那霉素筛选出阳性转化子,经过最佳IPTG诱导浓度、诱导时间与温度等一系列条件的摸索,获得MdproPO1重组蛋白高表达的mdproPO1/pET-30a/Rosetta菌株与最佳的诱导表达条件。
MdproPO1包涵体的纯化:将高表达MdproPO1的菌株接种到含卡那霉素的液体LB培养基里,按最佳诱导表达条件,用IPTG诱导MdproPO1表达。将诱导后的发酵液离心,回收菌体细胞,冰浴中超声破碎细胞,再离心,表达的MdproPO1重组蛋白全在沉淀里,为包涵体,将其收集。
MdproPO1多克隆抗体的制备:将MdproPO1包涵体进行SDS-PAGE蛋白电泳,切出KCl显色的MdproPO1目标带,用生理盐水研磨成糊,再加等量的完全弗氏佐剂研磨至油包水的乳液,给家兔背部皮下分点注射。三周后,用不完全弗氏佐剂与MdproPO1蛋白胶同样研磨成乳液,给兔子进行第二次注射。隔两周,把MdproPO1蛋白胶研磨成乳液,给兔子进行肌肉注射。三天后,用免疫双扩散法检测到抗体含量稳定时,取兔子全血制备抗血清。每次给兔子注射的MdproPO1蛋白量约为200 µg/kg。
MdproPO1包涵体的变性与复性:用Buffer A与B洗净MdproPO1包涵体,去除杂蛋白。再用Buffer C充分变性并溶解包涵体,离心收上清、弃沉淀。上清与辅助Buffer混合后,先后用Buffer D与Buffer E分别透析两次,充分复性目的蛋白。
MdproPO1复性蛋白的纯化与鉴定:离心复性后的MdproPO1蛋白,留上清,过微孔滤膜后上His-Bind亲和柱纯化,获得MdproPO1复性蛋白。用MdproPO1多克隆抗体进行Westernblot鉴定MdproPO1复性蛋白。
MdproPO1复性蛋白的活性检测:将MdproPO1复性蛋白用家蝇血淋巴或Ca2+离子等激活剂激活,激活的MdproPO1复性蛋白转为了活性的MdPO1,能够催化L-多巴底物形成黑色素,黑色素越多,样品的A490越大,MdproPO1复性蛋白的活性越高。
MdproPO1复性蛋白的应用:MdproPO1复性蛋白可以受加热或受乙醇等化学试剂的激活转为氧化酚类物质的MdPO1氧化剂;也可以通过MdPO1催化黑色素形成作为黑化剂使用;还可以通过抗体封闭作为灭蝇剂使用;还可以作为抑制或杀灭病原体、提高个体免疫力的免疫剂使用。
本发明的有益效果是:(1)构建了mdproPO1/pET-30a原核表达载体。利用家蝇 mdproPO1基因ORF的两端序列和pET-30a载体多克隆位点中的Kpn I与Sal I酶切位点,使MdproPO1酶蛋白序列的N末端连接了表达载体上的组氨酸标签(His-tagged)。(2)高量表达了MdproPO1重组蛋白包涵体。将重组质粒mdproPO1/pET-30a转化大肠杆菌Rosetta,筛选出了高表达MdproPO1的mdproPO1/pET-30a/Rosetta菌株,表达的MdproPO1重组蛋白占菌体总蛋白的22%,且带组氨酸标签,便于亲和纯化。(3)制备了MdproPO1多克隆抗体。利用MdproPO1重组蛋白制备了兔多克隆抗体,该抗体可以用于MdproPO1酶蛋白产品的鉴定,还可以用于灭蝇剂的开发。(4)建立了MdproPO1包涵体变性与复性的有效方法,获得了有活性的可溶性MdproPO1重组蛋白,可以通过MdproPO1重组蛋白上的His标签进行亲和层析纯化,获得更纯的产品作氧化剂、黑化剂和免疫剂等开发应用。
该法生产的可溶性MdproPO1重组蛋白具有简单方便、高效、易重复的优点。
附图说明
图1为SDS-PAGE检测的表达菌株mdproPO1/pET-30a/Rosetta大量表达MdproPO1蛋白的结果。随着IPTG诱导时间的增加,MdproPO1蛋白表达量在诱导1-5小时内不断增加,到5小时达到最大,约占菌体蛋白的22%。
图2为用SDS-PAGE与Western blot检测的MdproPO1包涵体变性与复性的结果。用MdproPO1重组蛋白制备的兔多克隆抗体检测,MdproPO1包涵体经变性与复性转变成了可溶性蛋白,其大小同家蝇的MdproPO1天然蛋白。
图3 是酶标仪检测MdproPO1复性蛋白活性的结果。经检测,MdproPO1复性蛋白可以为家蝇血淋巴激活,其MdPO1活性大大增加。
图4是用酶标仪检测的MdproPO1抗体封闭家蝇的MdPO1酶活性与家蝇死亡数的统计结果。结果显示,MdproPO1抗体封闭后,家蝇内源MdPO1酶活性下降、死亡率增加。
具体实施方式
下面结合实施例对本发明作进一步的说明。
实施例1
MdproPO1重组酶的表达
主要步骤包括:
用1 mL的无菌注射器针头蘸取等量混合的大肠杆菌(Escherichia coli)和金黄色葡萄球菌(Staphylococcus aureus)活菌液(浓度约3 * 108 cfu/mL),轻刺家蝇三龄幼虫后腹部,每虫一针,转入新鲜培养基中饲养4 h,提取刺激家蝇的总RNA反转录成cDNA为模板,合成含Kpn I与Sal I内切酶位点的正反向引物,引物序列为:
mdproPO1 ExF: 5‘—TAGatc GGTACC ATGACTGACAAAAAGAATCTCC—3’ (SEQ IDNO.3)
mdproPO1 ExR:5‘—TAG GTCGAC GCTGGCTGGAGAAAACTTAT—3’ (SEQ ID NO.4);
经聚合酶链式反应(PCR),扩增出2055 bp的mdproPO1基因的ORF,将其克隆入pET-30a质粒(Invitrogen),构建mdproPO1/pET-30a表达载体,转化大肠杆菌Rosetta,挑取阳性单菌落接种于含75 µg/mL卡那霉素的液体LB培养基里,37℃ 200 rpm振荡培养过夜。次日,按1/100的比例转接过夜培养菌至新的含卡那霉素的液体LB培养基里,30℃ 200 rpm振荡培养2.5 h,加入IPTG至终浓度0.5 mM,继续30℃振荡培养5 h,MdproPO1重组酶的表达量最大,见图1。
实施例2
MdproPO1包涵体的纯化、变性与复性
主要步骤包括:
ⅰ.包涵体的纯化:将MdproPO1表达量达最大的诱导菌液经7000 rpm 离心10 min,收菌体,用l × PBS(140 mM NaCl,2.7 mM KCl,10 mM Na2HPO4,1.8 Mm KH2PO4,pH7.4)重悬,冰浴中超声波破碎后, 4℃ 12000 rpm离心10 min,分开收集上清与沉淀,表达的MdproPO1重组蛋白全在沉淀里,为包涵体,大小与预计的83.5 kDa相符,包括mdproPO1基因2055 bp的ORF的编码蛋白,79.3 kDa,和载体上的His标签,约4.2 kDa(图2)。
ⅱ.包涵体的变性:将离心收集到的MdproPO1包涵体,用Buffer A(50 mM Tris-HCl、5 mM EDTA,pH 8.0)悬起,4℃ 10000 rpm 离心20 min,弃上清,重复一次,去除可溶性杂蛋白。再用Buffer B(50 mM Tris-HCl、5 mM EDTA、2 M脲,pH 8.0)将MdproPO1包涵体悬起,4℃ 10000 rpm 离心20 min,弃上清,重复一次。沉淀再用Buffer C(0.1 M Tris-HCl、10 mM DTT、8 M脲加水溶解,pH 8.0)悬起,37℃快速震荡1 h,充分变性并溶解包涵体蛋白,4℃ 12000 rpm 离心20 min,弃沉淀,保留上清,为变性的包涵体蛋白。
ⅲ.包涵体的复性:将MdproPO1包涵体变性蛋白与辅助Buffer(0.5 mM Arg、5 mMGly、50μM CuCl2、0.5 mM NaCl、5%甘油)按7:13混合,用Buffer D(0.1 M Tris-HCl、5 mMEDTA、5 mM Cysteine、1 M脲,pH 8.0)4℃透析两次,再用不含脲的Buffer E(0.1 M Tris-HCl、5 mM EDTA、5 mM Cysteine,pH 8.0)4℃透析两次,每次透析16 h,充分复性目的蛋白。
ⅳ.MdproPO1复性蛋白的纯化:MdproPO1复性蛋白经4℃ 12000 rpm 离心20 min,留上清,过0.4 µm微孔滤膜,上His-Bind亲和柱纯化,当可溶的MdproPO1复性蛋白流经Ni2+琼脂糖亲和层析柱时,被Ni2+吸附,后用咪唑洗脱,获得了纯MdproPO1酶蛋白。用MdproPO1多克隆抗体对MdproPO1复性蛋白进行Western blot检测,有阳性带,大小与预期的一致(图2)。
ⅴ.MdproPO1复性蛋白的活性检测:用无菌品准备三组检测样品:
(1)组为30μl菌刺家蝇的血淋巴。制备方法:用1 mL注射器针头蘸取等量混合的大肠杆菌(E.coli)和金黄色葡萄球菌(S.aureus)菌液(浓度约3 × 108 cfu/mL),刺激家蝇三龄幼虫后腹部,每虫一针,刺激幼虫转入新鲜培养基中饲养4 h,冰浴下断头吸取血淋巴于170 µL抗凝剂中,取混合液30μl为测试样品;
(2)组为菌刺家蝇的血淋巴与MdproPO1复性蛋白的混合液,各15μl;(3)组为30μlMdproPO1复性蛋白。
把三组样品按表1配制反应液,先将不含L-多巴溶液的反应液加入96孔板中,30℃孵育5 min,再加30μL的L-多巴溶液,用酶标仪检测反应10 min内的样品的吸光度A490。结果显示:三组样品都有A490,其中,加了MdproPO1复性蛋白的家蝇血淋巴样品较其他两组样品的A490明显增高,证明MdproPO1复性蛋白能够被家蝇proPO系统特异性丝氨酸蛋白酶级联反应强烈激活,转为了高活性的MdPO1,催化L-多巴底物形成了更多的黑色素,而MdproPO1复性蛋白的A490也较高,说明MdproPO1复性蛋白可能为反应液里的Ca2+离子激活了,但激活力度不如家蝇血淋巴(图3)。
表1. 180μL反应液
实施例3
MdproPO1复性蛋白的应用
主要包括:
ⅰ.氧化剂:MdproPO1复性蛋白受加热或用乙醇等化学试剂激活转为MdPO1,MdPO1是氧化酚类物质的氧化剂,因此,MdproPO1复性蛋白可以开发为氧化剂。
ⅱ.黑化剂:MdproPO1复性蛋白受加热或Ca2+离子等激活形成MdPO1,MdPO1催化黑色素形成,因此,MdproPO1复性蛋白可以开发为黑化剂。
ⅲ.灭蝇剂与免疫剂:把家蝇幼虫分成四组,分别做以下处理:1组,不注射;2组,注射0.4μl (3×108 CFU/mL)大肠杆菌;3组,先注射0.4μl MdproPO1抗血清,30 min后再注射0.4μl大肠杆菌(3×108 CFU/mL);4组,先注射0.4μl前血清,30 min后再注射0.4μl大肠杆菌(3×108 CFU/mL)。每组3个重复,20 h后,计算各组家蝇的死亡率。结果显示,第3组家蝇的死亡数最高(图4),证明MdproPO1多克隆抗体封闭了家蝇体内的MdproPO1蛋白,减弱了家蝇对病原菌的免疫力,引起家蝇死亡数相比菌刺组的明显增加,因此,MdproPO1多克隆抗体可以开发为灭蝇剂,而MdproPO1重组蛋白可以开发为抑制或杀灭病原体的免疫剂。
<110>济南大学
<120>一种可溶性家蝇MdproPO1重组蛋白的生产方法及其应用
<141>
<160> 1
<210> 1
<211> 2169
<212> DNA
<213>家蝇(Musca domestica)
<221>重组酚氧化酶原1
<222> (1)...(2169)
<400>1
1 ATGCACCATC ATCATCATCA TTCTTCTGGT CTGGTGCCAC GCGGTTCTGG TATGAAAGAA
61 ACCGCTGCTG CTAAATTCGA ACGCCAGCAC ATGGACAGCC CAGATCTGGG TACCATGACT
121 GACAAAAAGA ATCTCCTGTT GCTGTTCGAC CGCCCCACCG AACCGGTGTT CATGGGAAAG
181 GGCAAAACAT CGACGGTCTT CGATGTTCCC GACAAGTACT TGACAAAACG TTACGAACGT
241 TTGGGCAATG AAATCCAAAG TCGTTTCGGC GAAAAGGCTG AACAACGTGT ACCGGTTAGG
301 GGAATATCCC TGCCCGATTT ACGTATTCCC ATGTCCTTGG GTCGTGATGA ACAATTCTCA
361 TTGTTCGTGC CACGTCATCG TCGCATTGCG GGTCGCTTGA TTGACATTTT CGTTGGCATG
421 CGCACCGTTG ATGATTTGCT CAGTGTTGCT GTGTATGCCC GTGATCGTGT CAATCCCTAT
481 TTGTTCAATT ATGCCCTCTC GGTGGCTTTG TTGCATCGCG AAGATACCAA GGGTTTGGAT
541 TTGCCCTCGT TTGCCCAGAA TTTCCCCGAT AAGTTTGTGG ATTCCCAGGT CTTCCGTCAG
601 GTGAGAGAGG AAGCCACAGT CGTGCCCGAT GGATCTCGCA TGCCAATTGT AGTTCCTCGT
661 GACTATACCG CTTCCGATTT GGATCCCGAA CATCGTCTGT GGTATTTCCG TGAGGATATG
721 GGCATCAATC TTCATCACTG GCATTGGCAT TTGGTTTATC CTTTCGAGGC TGGGGATCGC
781 CGTATTGTCG AGAAGGATCG TCGCGGTGAA CTTTTCTATT ACATGCATCA ACAGGTCATT
841 GCCCGCTACA ACATGGAACG TTTCAGCAGC AATTTGGCCC GTGTCACTAG ATTCAACAAC
901 TTCCGTGAAC CCATTGCTGA AGGTTATTTC CCCAAGATGG ATTCACTGGT TGCCAGCCGT
961 GCTTGGCCAC CACGTTTCGA TAATACTCCC ATCAAAGATT TGAATCGTGA ATTGGATCAA
1021 ATCAATTTGG ACATTTCAGA CTTGGAAAGA TGGCGTGATC GTATTTTCGA GGCCATCCAT
1081 CAAGGATTTG TGGTCGATGC CAGCGGCAAT CGTATTCCCT TGGATGAACG TCGTGGTATT
1141 GATATTCTGG GTAATATGTT GGAAGCTTCC ATCATTTCAC CCAATCAATC GGTGTATGGT
1201 GATTTCCATA ACATGGGTCA TGTCTTCATT TCCTATGCCC ACGATCCTGA TCATCGCCAT
1261 CTGGAGTCAT TCGGCGTAAT GGGTGATTCA GCCACTGCCA TGCGTGATCC TGTCTTCTAC
1321 AGATGGCATG CCTATATTGA TGATATTTTC CAAGAACACA AGACCCGTCT GACACCCTAC
1381 ACCTTGCCTC AATTGCAATA TGATGGTATA TCCATATCTG GACTCCAGGT TAGCTCTGAG
1441 GGTGGTCAAC CCAATGTTTT GAGCACATTC TGGCAACAAT CGGATGTTGA TTTGTCCCGT
1501 GGCATGGGCT TCGTGCCACG CGGTAATGTC TTTGCCCGTT TCACTCATTT GCAACACACA
1561 CCCTTCACCT ATACCATTAA TGTCAACAAT GACAGTGGCG CCCAACGTTT TGGCACCGTA
1621 CGCATCTTCA TAGCCCCCAA GACCGATGAA CGTGGTCAGC CATGGTTGTT CCGCGATCAA
1681 CGTCTGATGA TGGTGGAGTT GGATAAGTTT GTTGTGCAAT TGAATCCTGG CCAAAACACA
1741 ATTCGCCGCC GTTCAACAGA TTCCAGTGTT ACCATTCCAT TTGAACGTAC CTTCCGCAAC
1801 TTGGAGGTTA ATCGCCCAGC CCAAGGTAGC CCCGAAGAAT TGGAATTCAA TTTCTGCGGC
1861 TGTGGCTGGC CTCAGCATAT GTTGATACCA AAGGGTTTGC CCGGTGGCAT GCGTTGTGAA
1921 CTGTTTGTCA TGGTCTCCAA TTATGAAGAT GATCGGGTTG ATCAAACCCT GGTCGGTGCC
1981 TGCAGTGATG CCGCCTCATA CTGTGGTGTC CGTGATCGTC TCTATCCCGA TCGTCGCGCC
2041 ATGGGTTATC CCTTCGATCG TTTGCCTCGT CAAGGTGTTG ATCGTTTGGT CCAATTCCTA
2101 ACACCCAACA TGAGCATTGT TGATGTATCG ATTCGTCATG ATGCCAACAG AGTTGTAATG
2161 AGACAATAA
<120>一种可溶性家蝇MdproPO1重组蛋白的生产方法及其应用
<141>
<160> 1
<210> 2
<211> 722
<212> A A
<213>家蝇(Musca domestica)
<221>重组酚氧化酶原1
<222> (1)...(722)
<400>2
1 MHHHHHHSSG LVPRGSGMKE TAAAKFERQH MDSPDLGTMT DKKNLLLLFD RPTEPVFMGK
61 GKTSTVFDVP DKYLTKRYER LGNEIQSRFG EKAEQRVPVR GISLPDLRIP MSLGRDEQFS
121 LFVPRHRRIA GRLIDIFVGM RTVDDLLSVA VYARDRVNPY LFNYALSVAL LHREDTKGLD
181 LPSFAQNFPD KFVDSQVFRQ VREEATVVPD GSRMPIVVPR DYTASDLDPE HRLWYFREDM
241 GINLHHWHWH LVYPFEAGDR RIVEKDRRGE LFYYMHQQVI ARYNMERFSS NLARVTRFNN
301 FREPIAEGYF PKMDSLVASR AWPPRFDNTP IKDLNRELDQ INLDISDLER WRDRIFEAIH
361 QGFVVDASGN RIPLDERRGI DILGNMLEAS IISPNQSVYG DFHNMGHVFI SYAHDPDHRH
421 LESFGVMGDS ATAMRDPVFY RWHAYIDDIF QEHKTRLTPY TLPQLQYDGI SISGLQVSSE
481 GGQPNVLSTF WQQSDVDLSR GMGFVPRGNV FARFTHLQHT PFTYTINVNN DSGAQRFGTV
541 RIFIAPKTDE RGQPWLFRDQ RLMMVELDKF VVQLNPGQNT IRRRSTDSSV TIPFERTFRN
601 LEVNRPAQGS PEELEFNFCG CGWPQHMLIP KGLPGGMRCE LFVMVSNYED DRVDQTLVGA
661 CSDAASYCGV RDRLYPDRRA MGYPFDRLPR QGVDRLVQFL TPNMSIVDVS IRHDANRVVM
721 RQ
<160>2
<210>3
<211>34
<212>DNA
<213>人工序列
<220>
<221>misc_feature
<222>(1)..(34)
<223>引物
<400>3
1 TAG atc GGT ACC ATG ACT GAC AAA AAG AAT
31 CTC C
<210>4
<211>29
<212>DNA
<213>人工序列
<220>
<221>misc_feature
<222>(1)..(29)
<223>引物
<400>4
1 TAG GTC GAC GCT GGC TGG AGA AAA CTT AT
Claims (4)
1.一种可溶性家蝇MdproPO1重组蛋白的制备方法,包括以下步骤:
1)构建mdproPO1/pET-30a重组表达载体:用大肠杆菌Escherichia coli和金黄色葡萄球菌Staphylococcus aureus混合液诱导的家蝇幼虫的cDNA为模板,依据家蝇酚氧化酶原基因的核苷酸序列,合成一对扩增该基因ORF的原核表达特异引物,引物序列为:
mdproPO1 ExF:5’—TAGatcGGTACCATGACTGACAAAAAGAATCTCC—3’
mdproPO1 ExR:5’—TAGGTCGACGCTGGCTGGAGAAAACTTAT—3’
该引物包含Kpn I与Sal I内切酶位点,所述Kpn I内切酶位点对应碱基序列为GGTACC;所述Sal I对应碱基序列为GTCGAC;
经聚合酶链式反应,扩增出2071bp的MdproPO1的ORF片段,通过两个内切酶酶切位点Kpn I与Sal I,将其克隆入pET-30a质粒,构建mdproPO1/pET-30a重组表达载体,
所述MdproPO1的核苷酸序列如SEQ ID NO:1所示;
2)获得mdproPO1/pET-30a/Rosetta高表达MdproPO1蛋白的表达菌株:将构建好的mdproPO1/pET-30a表达载体转化大肠杆菌Escherichia coli Rosetta感受态细胞,通过筛选,获得高表达MdproPO1重组蛋白的菌株mdproPO1/pET-30a/Rosetta;
3)表达菌株的发酵培养,加入IPTG至终浓度0.5 mM诱导表达5 h,获得MdproPO1包涵体;
4)MdproPO1包涵体的变性与复性,获得可溶的有活性的MdproPO1重组蛋白:用缓冲液A与B洗净MdproPO1包涵体;再用缓冲液 C充分变性并溶解包涵体,离心收上清、弃沉淀;上清与辅助缓冲液混合后,先后用缓冲液 D与缓冲液 E分别透析两次,充分复性目的蛋白;其中,
缓冲液 A成分为:50 mM Tris-HCl、5 mM EDTA,pH 8.0;
缓冲液 B成分为:50 mM Tris-HCl、5 mM EDTA、2 M脲,pH 8.0;
缓冲液 C成分为:0.1 M Tris-HCl、10 mM DTT、8 M脲加水溶解,pH 8.0;
缓冲液 D成分为:0.1 M Tris-HCl、5 mM EDTA、5 mM半胱氨酸、1 M脲,pH 8.0;
缓冲液 E成分为:0.1 M Tris-HCl、5 mM EDTA、5 mM半胱氨酸,pH 8.0;
辅助缓冲液成分为:0.5 mM精氨酸、5 mM 甘氨酸、50μM CuCl2、0.5 mM NaCl、5%甘油;
MdproPO1的氨基酸序列如SEQ ID NO:2所示。
2.一种权利要求1中制备的家蝇MdproPO1重组蛋白在制备灭蝇剂中的应用。
3.一种权利要求1中制备的家蝇MdproPO1重组蛋白在制备氧化剂中的应用。
4.一种权利要求1中制备的家蝇MdproPO1重组蛋白在制备黑化剂中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610806990.7A CN106479987B (zh) | 2016-09-07 | 2016-09-07 | 一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610806990.7A CN106479987B (zh) | 2016-09-07 | 2016-09-07 | 一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106479987A CN106479987A (zh) | 2017-03-08 |
CN106479987B true CN106479987B (zh) | 2020-03-24 |
Family
ID=58273846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610806990.7A Expired - Fee Related CN106479987B (zh) | 2016-09-07 | 2016-09-07 | 一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106479987B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108409850A (zh) * | 2018-01-30 | 2018-08-17 | 河南师范大学 | 一种鱼源半乳糖凝集素CaGal重组蛋白的制备方法及其应用 |
CN114990228A (zh) * | 2022-04-21 | 2022-09-02 | 济南大学 | 一种绿色灭蝇剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101942473A (zh) * | 2010-08-17 | 2011-01-12 | 山东大学 | 克氏原螯虾i型溶菌酶基因及其编码的溶菌酶与应用 |
-
2016
- 2016-09-07 CN CN201610806990.7A patent/CN106479987B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101942473A (zh) * | 2010-08-17 | 2011-01-12 | 山东大学 | 克氏原螯虾i型溶菌酶基因及其编码的溶菌酶与应用 |
Non-Patent Citations (4)
Title |
---|
Musca domestica phenoloxidase mRNA,GenBank: AY494738.1,2376bp mRNA linear;Geng H.等;《NCBI genbank》;20151229;1-2 * |
Transcriptomic analysis of Musca domestica to reveal key genes of the prophenoloxidase-activating system;Dianxiang Li等;《G3 (Bethesda)》;20150930;第5卷(第9期);1827-1841 * |
三种家蝇酚氧化酶基因表达差异研究;刘永春等;《济宁医学院学报》;20110228;第34卷(第1期);12-13、16 * |
家蝇对病原入侵黑化反应的研究;李殿香;《中华卫生杀虫药械》;20130630;第19卷(第3期);196-199 * |
Also Published As
Publication number | Publication date |
---|---|
CN106479987A (zh) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110194790B (zh) | 尖孢镰刀菌分泌的植物免疫激活蛋白FoPII1及其应用 | |
CN110922457B (zh) | 禾谷镰刀菌分泌的植物免疫诱抗蛋白FgPII1及其应用 | |
CN114752610B (zh) | 柑橘木虱泛素结合酶e2j2基因在防控柑橘黄龙病中的应用 | |
CN106244599B (zh) | 一种三七病程相关蛋白1家族基因PnPR1-2及应用 | |
CN110551732A (zh) | 一种卵形鲳鲹抗菌肽leap-2基因及应用 | |
CN111304181B (zh) | 一种基因工程改造后的副溶血性弧菌噬菌体裂解酶及其制备方法和应用 | |
CN106479987B (zh) | 一种可溶性家蝇MdproPO1重组蛋白的制备方法及其应用 | |
CN110408624A (zh) | 一种菲律宾蛤仔c型凝集素蛋白及其制备方法与应用 | |
CN112480227B (zh) | 一种提高鲟鱼抵抗病原菌能力的蛋白及其制备方法与应用 | |
CN101525617B (zh) | 中华绒螯蟹Crustin-1基因及体外重组表达 | |
WO2024037548A1 (zh) | 一种植物免疫激活蛋白PmSCR1及其应用 | |
CN110669114B (zh) | 一种羊毛硫肽前体肽amyA6及其制备方法和应用 | |
CN117384267A (zh) | 一种脊尾白虾抗菌肽、编码基因EcCrustin、重组菌及其应用 | |
CN105441469B (zh) | 重组昆虫蜕皮激素失活基因Bbsp::egt及其杀虫真菌剂 | |
CN109721646B (zh) | 一种诱导增强水稻稻瘟菌抗性的稻瘟菌分泌蛋白及其应用 | |
CN109021088B (zh) | 一种斑节对虾抗菌肽ALFpm10及其制备方法 | |
CN102094024A (zh) | 一种小菜蛾天蚕素基因、编码的蛋白、相应的表达系统和应用 | |
CN110894218A (zh) | 致病疫霉菌分泌的植物免疫激活蛋白scr50及其应用 | |
CN102094023A (zh) | 一种小菜蛾葛佬素基因及编码的蛋白、相应的表达系统和应用 | |
CN113150087B (zh) | 禾谷镰刀菌分泌的植物免疫激活蛋白Fg62及其应用 | |
CN101565703B (zh) | 中华绒螯蟹Crustin-2基因及其重组蛋白的应用 | |
CN103484466A (zh) | 一种小菜蛾抗菌肽moricin及其制备方法与应用 | |
CN109706136B (zh) | 用作pcr防腐剂的裂解酶及其制备方法和应用 | |
CN109251936B (zh) | 一种光滑鳖甲丝氨酸蛋白酶抑制剂融合蛋白及制备与应用 | |
CN110257409B (zh) | 一种红螯螯虾孵化酶基因及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200324 |